F
Femasys Inc. (FEMY)
NCM – Real Time Price. Currency in USD
0.38
-0.03 (-6.70%)
At close: May 12, 2026, 4:00 PM EDT
0.39
+0.01 (3.47%)
After-hours: May 12, 2026, 7:16 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.38
-0.03 (-6.70%)
At close: May 12, 2026, 4:00 PM EDT
0.39
+0.01 (3.47%)
After-hours: May 12, 2026, 7:16 PM EDT
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women’s reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
| Name | Position |
|---|---|
| Dr. James H. Liu M.D. | Chief Medical Officer |
| Dr. Jeffrey Marcus M.D., M.S. | Chief Medical Advisor |
| Mr. Benjamin Dings | Vice President of Sales |
| Mr. Dov Elefant | Chief Financial Officer |
| Mr. Jeremy Alexander Sipos | Chief Technology Officer |
| Mr. John Canning | Chief Operating Officer |
| Ms. Christine Thomas | Senior VP of Regulatory & Clinical Affairs |
| Ms. Kathy Lee-Sepsick M.B.A. | Founder, President, CEO & Director |
| Ms. Mary An Merchant J.D., Ph.D. | Vice President of Counsel & Intellectual Property |
| Ms. Megan Eckerman | Senior Vice President of Global Marketing |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 8-K | ef20072749_8k.htm |
| 2026-04-30 | DEF 14A | ef20071760_def14a.htm |
| 2026-04-29 | 8-K | ef20071893_8k.htm |
| 2026-04-06 | DEF 14A | ef20069692_def14a.htm |
| 2026-04-01 | 8-K | ef20069522_8k.htm |
| 2026-03-31 | S-8 | ef20068660_s8.htm |
| 2026-03-27 | PRE 14A | ef20069129_pre14a.htm |
| 2026-03-20 | 8-K | ef20068469_form8k.htm |
| 2026-01-15 | 8-K | ef20063173_8k.htm |
| 2025-12-31 | S-3 | ny20062180x1_s3.htm |